From: Consistency, comprehensiveness, and compatibility of pathway databases
Pathway 1 | Pathway 2 |
---|---|
ErbB signaling pathway | JAK/Stat Signaling |
Calcium signaling pathway | Synaptic Long Term Potentiation |
Apoptosis | Toll-like receptor signaling pathway |
VEGF signaling pathway | Axonal Guidance Signaling |
Gap junction | PPAR-alpha/RXR-alpha Signaling |
Natural killer cell mediated cytotoxicity | Fc Epsilon RI Signaling |
T cell receptor signaling pathway | Axonal Guidance Signaling |
B cell receptor signaling pathway | Axonal Guidance Signaling |
Olfactory transduction | cAMP-mediated Signaling |
GnRH signaling pathway | B Cell Receptor Signaling |
Melanogenesis | Wnt Signaling Pathway and Pluripotency |
Type II diabetes mellitus | Insulin Recpetor Signaling |
Colorectal cancer | Toll-like receptor signaling pathway |
Renal cell carcinoma | Axonal Guidance Signaling |
Pancreatic cancer | PTEN Signaling |
Endometrial cancer | PTEN Signaling |
Glioma | ERK/MAPK Signaling |
Prostate cancer | JAK/Stat Signaling |
Basal cell carcinoma | Wnt Signaling Pathway and Pluripotency |
Melanoma | FGF Signaling |
Chronic myeloid leukemia | GM-CSF Signaling |
Acute myeloid leukemia | PTEN Signaling |
Small cell lung cancer | Toll-like receptor signaling pathway |
Non-small cell lung cancer | GM-CSF Signaling |